AU2002323286A1 - Human toxicologically relevant genes and arrays - Google Patents
Human toxicologically relevant genes and arraysInfo
- Publication number
- AU2002323286A1 AU2002323286A1 AU2002323286A AU2002323286A AU2002323286A1 AU 2002323286 A1 AU2002323286 A1 AU 2002323286A1 AU 2002323286 A AU2002323286 A AU 2002323286A AU 2002323286 A AU2002323286 A AU 2002323286A AU 2002323286 A1 AU2002323286 A1 AU 2002323286A1
- Authority
- AU
- Australia
- Prior art keywords
- arrays
- human
- relevant genes
- toxicologically relevant
- toxicologically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31308001P | 2001-08-16 | 2001-08-16 | |
US60/313,080 | 2001-08-16 | ||
PCT/US2002/026514 WO2003016500A2 (en) | 2001-08-16 | 2002-08-16 | Human toxicologically relevant genes and arrays |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002323286A1 true AU2002323286A1 (en) | 2003-03-03 |
Family
ID=23214292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002323286A Abandoned AU2002323286A1 (en) | 2001-08-16 | 2002-08-16 | Human toxicologically relevant genes and arrays |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1427850A4 (en) |
AU (1) | AU2002323286A1 (en) |
WO (1) | WO2003016500A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050283854A1 (en) | 2003-05-23 | 2005-12-22 | Anton Krumm | Recombinant vectors for use in position-independent transgene expression within chromatin |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
WO2006060393A2 (en) * | 2004-11-30 | 2006-06-08 | Bg Medicine, Inc. | Biological systems analysis |
FR2890080B1 (en) * | 2005-08-30 | 2012-12-14 | Vigilent Technologies | IN VITRO METHOD FOR TESTING THE TOXICITY OF A COMPOUND AND DEVICE FOR IMPLEMENTING SAID METHOD |
WO2008023671A1 (en) * | 2006-08-24 | 2008-02-28 | Hiroshima University | Method for highly amplifying target gene in mammalian cell and vector therefor |
RU2693462C2 (en) | 2010-05-03 | 2019-07-03 | Курна, Инк. | Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to sirtuin (sirt) |
KR102165245B1 (en) * | 2013-05-21 | 2020-10-13 | 한양대학교 에리카산학협력단 | Method for determining probability of exposure to toxic chemicals |
GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
WO2021242819A1 (en) * | 2020-05-29 | 2021-12-02 | The Trustees Of The University Of Pennsylvania | Compositions and methods of detecting respiratory viruses including coronaviruses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811231A (en) * | 1993-01-21 | 1998-09-22 | Pres. And Fellows Of Harvard College | Methods and kits for eukaryotic gene profiling |
US6160105A (en) * | 1998-10-13 | 2000-12-12 | Incyte Pharmaceuticals, Inc. | Monitoring toxicological responses |
WO2001011030A2 (en) * | 1999-08-10 | 2001-02-15 | Develogen Ag Für Entwicklungsbiologische Forschung | Method and means for inducing cell-multiplication of non-active cells |
AU1466001A (en) * | 1999-11-05 | 2001-05-14 | Phase-1 Molecular Toxicology | Methods of determining individual hypersensitivity to an agent |
US20020192671A1 (en) * | 2001-01-23 | 2002-12-19 | Castle Arthur L. | Method and system for predicting the biological activity, including toxicology and toxicity, of substances |
EP1534739A4 (en) * | 2002-01-18 | 2006-05-31 | Bristol Myers Squibb Co | Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
-
2002
- 2002-08-16 EP EP02757259A patent/EP1427850A4/en not_active Withdrawn
- 2002-08-16 WO PCT/US2002/026514 patent/WO2003016500A2/en not_active Application Discontinuation
- 2002-08-16 AU AU2002323286A patent/AU2002323286A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003016500A2 (en) | 2003-02-27 |
WO2003016500A3 (en) | 2003-06-19 |
EP1427850A2 (en) | 2004-06-16 |
EP1427850A4 (en) | 2006-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002348226A1 (en) | Invasive therapeutic probe | |
WO2003018621A8 (en) | Genes | |
EP1247815A3 (en) | Modified oligonucleotides and uses thereof | |
AU2002356664A1 (en) | Beta-amino-alpha-cyanoacrylates and their use as herbicides | |
AU2002336288A1 (en) | Weed controller metabolism proteins, genes thereof and use of the same | |
AU2002252976A1 (en) | Hydrazones and their therapeutic use | |
AU2002258728A1 (en) | Gene brcc-3 and diagnostic and therapeutic uses thereof | |
AU2002303261A1 (en) | Gene brcc2 and diagnostic and therapeutic uses thereof | |
AU2002305151A1 (en) | Gene scc-112 and diagnostic and therapeutic uses thereof | |
AU2002323286A1 (en) | Human toxicologically relevant genes and arrays | |
AU2002258387A1 (en) | Rat toxicologically relevant genes and uses thereof | |
AU2003223878A1 (en) | Heating conductor and use thereof | |
GB0127657D0 (en) | Virulence genes and proteins and their use | |
AU2001268053A1 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof | |
AU2001287269A1 (en) | Human genes and expression products | |
AU2002240921A1 (en) | Medane genes and proteins | |
AU2002322224A1 (en) | Isp-1 and ctb-1 genes and uses thereof | |
AU2002303262A1 (en) | Gene shinc-1 and diagnostic and therapeutic uses thereof | |
EP1426443A4 (en) | Novel human bmcc1 gene | |
AU2002953516A0 (en) | Genetic therapy and genetic modification | |
GB0105922D0 (en) | Genes and proteins, and their use | |
AU2002322013A1 (en) | Therapeutic dna vaccination | |
AU2002321141A1 (en) | Pyrimidinoxyalkylpiperazines and their therapeutic use | |
AU2002240094A1 (en) | Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof | |
AU2002226691A1 (en) | Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |